Cargando…
Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma
Glioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of glioma. As we all know, surgical resection, chemotherapy, and radiotherapy are the main treatment meth...
Autores principales: | Xie, Yandong, Han, Yuhan, Zhang, Xuefeng, Ma, Hongwei, Li, Linfeng, Yu, Rutong, Liu, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044949/ https://www.ncbi.nlm.nih.gov/pubmed/33869019 http://dx.doi.org/10.3389/fonc.2021.633827 |
Ejemplares similares
-
Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
por: Metselaar, Dennis S., et al.
Publicado: (2021) -
Role of Borneol Induced Autophagy in Enhancing Radiosensitivity of Malignant Glioma
por: Li, Qinglin, et al.
Publicado: (2021) -
Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy
por: Hua, Lei, et al.
Publicado: (2018) -
The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022) -
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
por: Wu, Shan, et al.
Publicado: (2020)